Global Myotonic Dystrophy Type 1 (DM1) Market Research Report 2024

Report ID: 1858393 | Published Date: Jan 2025 | No. of Page: 99 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Myotonic Dystrophy Type 1 (DM1) Market Overview
    1.1 Product Overview and Scope of Myotonic Dystrophy Type 1 (DM1)
    1.2 Myotonic Dystrophy Type 1 (DM1) Segment by Type
        1.2.1 Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Exondys
        1.2.3 Emflaza
        1.2.4 Translarna
    1.3 Myotonic Dystrophy Type 1 (DM1) Segment by Application
        1.3.1 Global Myotonic Dystrophy Type 1 (DM1) Sales Comparison by Application: (2022-2028)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Home Care
    1.4 Global Myotonic Dystrophy Type 1 (DM1) Market Size Estimates and Forecasts
        1.4.1 Global Myotonic Dystrophy Type 1 (DM1) Revenue 2017-2028
        1.4.2 Global Myotonic Dystrophy Type 1 (DM1) Sales 2017-2028
        1.4.3 Myotonic Dystrophy Type 1 (DM1) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Myotonic Dystrophy Type 1 (DM1) Market Competition by Manufacturers
    2.1 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Myotonic Dystrophy Type 1 (DM1) Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Myotonic Dystrophy Type 1 (DM1) Manufacturing Sites, Area Served, Product Type
    2.5 Myotonic Dystrophy Type 1 (DM1) Market Competitive Situation and Trends
        2.5.1 Myotonic Dystrophy Type 1 (DM1) Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Myotonic Dystrophy Type 1 (DM1) Players Market Share by Revenue
        2.5.3 Global Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Myotonic Dystrophy Type 1 (DM1) Retrospective Market Scenario by Region
    3.1 Global Myotonic Dystrophy Type 1 (DM1) Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Myotonic Dystrophy Type 1 (DM1) Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
        3.3.1 North America Myotonic Dystrophy Type 1 (DM1) Sales by Country
        3.3.2 North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
        3.4.1 Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country
        3.4.2 Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Region
        3.5.1 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region
        3.5.2 Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
        3.6.1 Latin America Myotonic Dystrophy Type 1 (DM1) Sales by Country
        3.6.2 Latin America Myotonic Dystrophy Type 1 (DM1) Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
        3.6.6 Colombia
    3.7 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Market Facts & Figures by Country
        3.7.1 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales by Country
        3.7.2 Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Myotonic Dystrophy Type 1 (DM1) Historic Market Analysis by Type
    4.1 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)
    4.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Type (2017-2022)
    4.3 Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2017-2022)
5 Global Myotonic Dystrophy Type 1 (DM1) Historic Market Analysis by Application
    5.1 Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)
    5.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Application (2017-2022)
    5.3 Global Myotonic Dystrophy Type 1 (DM1) Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Dyne
        6.1.1 Dyne Corporation Information
        6.1.2 Dyne Description and Business Overview
        6.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Dyne Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.1.5 Dyne Recent Developments/Updates
    6.2 Audentes
        6.2.1 Audentes Corporation Information
        6.2.2 Audentes Description and Business Overview
        6.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Audentes Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.2.5 Audentes Recent Developments/Updates
    6.3 Pfizer
        6.3.1 Pfizer Corporation Information
        6.3.2 Pfizer Description and Business Overview
        6.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.3.5 Pfizer Recent Developments/Updates
    6.4 Vertex
        6.4.1 Vertex Corporation Information
        6.4.2 Vertex Description and Business Overview
        6.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Vertex Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.4.5 Vertex Recent Developments/Updates
    6.5 PepGen
        6.5.1 PepGen Corporation Information
        6.5.2 PepGen Description and Business Overview
        6.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 PepGen Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.5.5 PepGen Recent Developments/Updates
    6.6 NeuBase Therapeutics
        6.6.1 NeuBase Therapeutics Corporation Information
        6.6.2 NeuBase Therapeutics Description and Business Overview
        6.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.6.5 NeuBase Therapeutics Recent Developments/Updates
    6.7 Lupin
        6.6.1 Lupin Corporation Information
        6.6.2 Lupin Description and Business Overview
        6.6.3 Lupin Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 Lupin Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.7.5 Lupin Recent Developments/Updates
    6.8 AMO Pharma
        6.8.1 AMO Pharma Corporation Information
        6.8.2 AMO Pharma Description and Business Overview
        6.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.8.5 AMO Pharma Recent Developments/Updates
    6.9 Expansion Therapeutics
        6.9.1 Expansion Therapeutics Corporation Information
        6.9.2 Expansion Therapeutics Description and Business Overview
        6.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.9.5 Expansion Therapeutics Recent Developments/Updates
    6.10 Harmony Biosciences
        6.10.1 Harmony Biosciences Corporation Information
        6.10.2 Harmony Biosciences Description and Business Overview
        6.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Portfolio
        6.10.5 Harmony Biosciences Recent Developments/Updates
7 Myotonic Dystrophy Type 1 (DM1) Manufacturing Cost Analysis
    7.1 Myotonic Dystrophy Type 1 (DM1) Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Myotonic Dystrophy Type 1 (DM1)
    7.4 Myotonic Dystrophy Type 1 (DM1) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Myotonic Dystrophy Type 1 (DM1) Distributors List
    8.3 Myotonic Dystrophy Type 1 (DM1) Customers
9 Myotonic Dystrophy Type 1 (DM1) Market Dynamics
    9.1 Myotonic Dystrophy Type 1 (DM1) Industry Trends
    9.2 Myotonic Dystrophy Type 1 (DM1) Market Drivers
    9.3 Myotonic Dystrophy Type 1 (DM1) Market Challenges
    9.4 Myotonic Dystrophy Type 1 (DM1) Market Restraints
10 Global Market Forecast
    10.1 Myotonic Dystrophy Type 1 (DM1) Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Myotonic Dystrophy Type 1 (DM1) by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Myotonic Dystrophy Type 1 (DM1) by Type (2023-2028)
    10.2 Myotonic Dystrophy Type 1 (DM1) Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Myotonic Dystrophy Type 1 (DM1) by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Myotonic Dystrophy Type 1 (DM1) by Application (2023-2028)
    10.3 Myotonic Dystrophy Type 1 (DM1) Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Myotonic Dystrophy Type 1 (DM1) by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Myotonic Dystrophy Type 1 (DM1) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
    Table 2. Global Myotonic Dystrophy Type 1 (DM1) Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
    Table 3. Global Myotonic Dystrophy Type 1 (DM1) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Myotonic Dystrophy Type 1 (DM1) Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Myotonic Dystrophy Type 1 (DM1) Sales (Units) of Key Manufacturers (2017-2022)
    Table 6. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Myotonic Dystrophy Type 1 (DM1) Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Myotonic Dystrophy Type 1 (DM1) Manufacturing Sites and Area Served
    Table 11. Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Myotonic Dystrophy Type 1 (DM1) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Myotonic Dystrophy Type 1 (DM1) as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Myotonic Dystrophy Type 1 (DM1) Sales by Region (2017-2022) & (Units)
    Table 16. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2022)
    Table 17. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2017-2022)
    Table 19. North America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)
    Table 20. North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2022)
    Table 21. North America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2022)
    Table 23. Europe Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)
    Table 24. Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2022)
    Table 25. Europe Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales by Region (2017-2022) & (Units)
    Table 28. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)
    Table 32. Latin America Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2022)
    Table 33. Latin America Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales by Country (2017-2022) & (Units)
    Table 36. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Country (2017-2022)
    Table 39. Global Myotonic Dystrophy Type 1 (DM1) Sales by Type (2017-2022) & (Units)
    Table 40. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Type (2017-2022)
    Table 41. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Type (2017-2022)
    Table 43. Global Myotonic Dystrophy Type 1 (DM1) Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Myotonic Dystrophy Type 1 (DM1) Sales (Units) by Application (2017-2022)
    Table 45. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Application (2017-2022)
    Table 46. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Application (2017-2022)
    Table 48. Global Myotonic Dystrophy Type 1 (DM1) Price by Application (2017-2022) & (US$/Unit)
    Table 49. Dyne Corporation Information
    Table 50. Dyne Description and Business Overview
    Table 51. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Dyne Myotonic Dystrophy Type 1 (DM1) Product
    Table 53. Dyne Recent Developments/Updates
    Table 54. Audentes Corporation Information
    Table 55. Audentes Description and Business Overview
    Table 56. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Audentes Myotonic Dystrophy Type 1 (DM1) Product
    Table 58. Audentes Recent Developments/Updates
    Table 59. Pfizer Corporation Information
    Table 60. Pfizer Description and Business Overview
    Table 61. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Pfizer Myotonic Dystrophy Type 1 (DM1) Product
    Table 63. Pfizer Recent Developments/Updates
    Table 64. Vertex Corporation Information
    Table 65. Vertex Description and Business Overview
    Table 66. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. Vertex Myotonic Dystrophy Type 1 (DM1) Product
    Table 68. Vertex Recent Developments/Updates
    Table 69. PepGen Corporation Information
    Table 70. PepGen Description and Business Overview
    Table 71. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. PepGen Myotonic Dystrophy Type 1 (DM1) Product
    Table 73. PepGen Recent Developments/Updates
    Table 74. NeuBase Therapeutics Corporation Information
    Table 75. NeuBase Therapeutics Description and Business Overview
    Table 76. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product
    Table 78. NeuBase Therapeutics Recent Developments/Updates
    Table 79. Lupin Corporation Information
    Table 80. Lupin Description and Business Overview
    Table 81. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. Lupin Myotonic Dystrophy Type 1 (DM1) Product
    Table 83. Lupin Recent Developments/Updates
    Table 84. AMO Pharma Corporation Information
    Table 85. AMO Pharma Description and Business Overview
    Table 86. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product
    Table 88. AMO Pharma Recent Developments/Updates
    Table 89. Expansion Therapeutics Corporation Information
    Table 90. Expansion Therapeutics Description and Business Overview
    Table 91. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product
    Table 93. Expansion Therapeutics Recent Developments/Updates
    Table 94. Harmony Biosciences Corporation Information
    Table 95. Harmony Biosciences Description and Business Overview
    Table 96. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product
    Table 98. Harmony Biosciences Recent Developments/Updates
    Table 99. Production Base and Market Concentration Rate of Raw Material
    Table 100. Key Suppliers of Raw Materials
    Table 101. Myotonic Dystrophy Type 1 (DM1) Distributors List
    Table 102. Myotonic Dystrophy Type 1 (DM1) Customers List
    Table 103. Myotonic Dystrophy Type 1 (DM1) Market Trends
    Table 104. Myotonic Dystrophy Type 1 (DM1) Market Drivers
    Table 105. Myotonic Dystrophy Type 1 (DM1) Market Challenges
    Table 106. Myotonic Dystrophy Type 1 (DM1) Market Restraints
    Table 107. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Type (2023-2028) & (Units)
    Table 108. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Forecast by Type (2023-2028)
    Table 109. Global Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 110. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share Forecast by Type (2023-2028)
    Table 111. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Application (2023-2028) & (Units)
    Table 112. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Forecast by Application (2023-2028)
    Table 113. Global Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 114. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share Forecast by Application (2023-2028)
    Table 115. Global Myotonic Dystrophy Type 1 (DM1) Sales Forecast by Region (2023-2028) & (Units)
    Table 116. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share Forecast by Region (2023-2028)
    Table 117. Global Myotonic Dystrophy Type 1 (DM1) Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 118. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share Forecast by Region (2023-2028)
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Myotonic Dystrophy Type 1 (DM1)
    Figure 2. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Type in 2021 & 2028
    Figure 3. Exondys Product Picture
    Figure 4. Emflaza Product Picture
    Figure 5. Translarna Product Picture
    Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Market Share by Application in 2021 & 2028
    Figure 7. Hospitals
    Figure 8. Clinics
    Figure 9. Home Care
    Figure 10. Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Myotonic Dystrophy Type 1 (DM1) Market Size (2017-2028) & (US$ Million)
    Figure 12. Global Myotonic Dystrophy Type 1 (DM1) Sales (2017-2028) & (Units)
    Figure 13. Myotonic Dystrophy Type 1 (DM1) Sales Share by Manufacturers in 2021
    Figure 14. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Manufacturers in 2021
    Figure 15. The Global 5 and 10 Largest Myotonic Dystrophy Type 1 (DM1) Players: Market Share by Revenue in 2021
    Figure 16. Myotonic Dystrophy Type 1 (DM1) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 17. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region (2017-2022)
    Figure 18. Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share by Region in 2021
    Figure 19. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region (2017-2022)
    Figure 20. Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share by Region in 2021
    Figure 21. United States Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 22. Canada Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 23. Germany Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. France Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. U.K. Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. Italy Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. Russia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. China Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Japan Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. South Korea Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. India Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. Australia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. China Taiwan Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Indonesia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. Thailand Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Malaysia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Mexico Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Brazil Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Argentina Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Colombia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Turkey Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. UAE Myotonic Dystrophy Type 1 (DM1) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. Sales Market Share of Myotonic Dystrophy Type 1 (DM1) by Type (2017-2022)
    Figure 45. Manufacturing Cost Structure of Myotonic Dystrophy Type 1 (DM1)
    Figure 46. Manufacturing Process Analysis of Myotonic Dystrophy Type 1 (DM1)
    Figure 47. Myotonic Dystrophy Type 1 (DM1) Industrial Chain Analysis
    Figure 48. Channels of Distribution
    Figure 49. Distributors Profiles
    Figure 50. Bottom-up and Top-down Approaches for This Report
    Figure 51. Data Triangulation
    Figure 52. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Dyne
Audentes
Pfizer
Vertex
PepGen
NeuBase Therapeutics
Lupin
AMO Pharma
Expansion Therapeutics
Harmony Biosciences
Frequently Asked Questions
Myotonic Dystrophy Type 1 (DM1) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Myotonic Dystrophy Type 1 (DM1) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Myotonic Dystrophy Type 1 (DM1) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

EC Fan Motor

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

E-Frac

E-Frac market is segmented by players, region (country), by Type and by Application. Players, sta ... Read More

Switch Aggregation

Switch Aggregation market is segmented by players, region (country), by Type and by Application.  ... Read More